HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio Ríos Selected Research

HLA-C*02 antigen

1/2004Frequency of HLA-C alleles in differentiated thyroid carcinoma in southeastern Spain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio Ríos Research Topics

Disease

10Neoplasms (Cancer)
02/2022 - 01/2004
7Goiter
11/2019 - 01/2005
4Carcinoma (Carcinomatosis)
01/2015 - 01/2004
3Brain Death (Brain Dead)
03/2020 - 10/2017
3Hemorrhage
11/2014 - 03/2007
3Substernal Goiter
05/2010 - 02/2006
2Glioblastoma (Glioblastoma Multiforme)
07/2015 - 08/2013
2Thyroid Neoplasms (Thyroid Cancer)
02/2006 - 01/2004
1Carcinogenesis
02/2022
1COVID-19
08/2020
1Cadaver (Cadavers)
06/2020
1Papillary Thyroid Microcarcinoma
05/2020
1Brain Diseases (Brain Disorder)
03/2020
1Hypocalcemia
11/2019
1Fistula
04/2019
1Papillary Thyroid Cancer
03/2019
1Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis)
01/2019
1Disease Progression
01/2019
1Thyroid Diseases (Thyroid Disease)
01/2019
1Cysts
01/2018
1Abdominal Pain (Pain, Abdominal)
03/2017
1Hyperplasia
03/2017
1Primary Hyperparathyroidism
01/2017
1Hepatoblastoma
07/2015
1Crohn Disease (Crohn's Disease)
12/2012
1Amyloidosis
12/2012
1Adenocarcinoma
07/2010
1Necrosis
01/2010
1Diarrhea
06/2007
1Protein-Energy Malnutrition (Marasmus)
06/2007
1Infections
04/2006
1Meckel Diverticulum
11/2005
1Knee Dislocation
09/2003
1Multiple Endocrine Neoplasia Type 2a (MEN 2)
08/2002
1Inflammation (Inflammations)
01/2002
1Ulcerative Colitis
01/2002

Drug/Important Bio-Agent (IBA)

2EnzymesIBA
02/2022 - 06/2007
2Choline KinaseIBA
02/2022 - 01/2019
2CholesterolIBA
07/2015 - 08/2013
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
06/2007 - 01/2002
2Fatty Acids (Saturated Fatty Acids)IBA
06/2007 - 01/2002
2HLA-C*70 antigenIBA
02/2006 - 01/2004
2HLA-Cw1 antigenIBA
02/2006 - 01/2004
2HLA-C Antigens (HLA-C)IBA
02/2006 - 01/2004
1Choline (Choline Chloride)IBA
02/2022
11,3,4,5,6-pentachlorocyclohexene-1-oxideIBA
02/2022
1Phosphatidylcholines (Phosphatidylcholine)IBA
02/2022
1Phosphorylcholine (Phosphocholine)IBA
02/2022
1Proteins (Proteins, Gene)FDA Link
02/2022
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
11/2019
1ferric oxide (iron oxide)IBA
03/2019
1Codon (Codons)IBA
01/2019
1S100 Proteins (S 100 Protein)IBA
03/2017
1Phosphopyruvate Hydratase (Enolase)IBA
03/2017
1perifosineIBA
07/2015
1ThyroglobulinFDA Link
01/2015
1Dihydrotachysterol (AT 10)IBA
01/2015
1Therapeutic UsesIBA
11/2014
1Amyloid (Amyloid Fibrils)IBA
12/2012
1S 6 (S-6)IBA
02/2010
1S(8)IBA
02/2010
1ThymidineIBA
01/2010
1InosineFDA Link
01/2010
1CytidineIBA
01/2010
1UridineIBA
01/2010
1GuanosineIBA
01/2010
13-Iodobenzylguanidine (Iobenguane)IBA
11/2008
1Olive OilIBA
06/2007
1LactoseFDA LinkGeneric
06/2007
1CatalaseIBA
06/2007
1Phospholipids (Phosphatides)FDA LinkGeneric
06/2007
1CarbohydratesIBA
06/2007
1AntioxidantsIBA
06/2007
1Superoxide DismutaseIBA
06/2007
1Fish OilsIBA
06/2007
1Glutathione PeroxidaseIBA
06/2007
1HLA-C*04 antigenIBA
02/2006
1AntibodiesIBA
01/2005
1Colloids (Colloid)IBA
12/2004
1HLA-C*02 antigenIBA
01/2004
1Prostaglandins EIBA
01/2002
1Alkaline PhosphataseIBA
01/2002
1Leukotriene B4IBA
01/2002
1Biomarkers (Surrogate Marker)IBA
01/2002
1ProstaglandinsIBA
01/2002

Therapy/Procedure

11Thyroidectomy
05/2020 - 08/2002
5Transplantation
08/2020 - 10/2017
3Sternotomy
08/2012 - 02/2010
3Colectomy
07/2010 - 11/2005
2Therapeutics
02/2022 - 08/2013
2Conservative Treatment
04/2019 - 01/2018
1Organ Transplantation
03/2020
1Liver Transplantation
03/2020
1Appendectomy
03/2017
1Parathyroidectomy
01/2017
1Therapeutic Embolization
09/2013
1Replantation
04/2006
1Knee Prosthesis
04/2006
1Punctures
12/2004
1Aftercare (After-Treatment)
09/2003